title: Eculizumab. A less burdensome treatment for atypical haemolytic uraemic syndrome?
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D002986:Clinical Trials as Topic; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab